{"title":"Clinical and Imaging Predictors of Hematoma Expansion in Spontaneous Intracerebral Hemorrhage: Development of a Prognostic Model.","authors":"Yi-Guang Mao, Jia-Yu Chen, Man-Li Wang, Ying-Jun Ma, Chen Jiang","doi":"10.2147/RMHP.S534564","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Identifying risk factors associated with hematoma expansion following spontaneous intracerebral hemorrhage (ICH) is essential for improving early intervention strategies. We hope to use this predictive model in the future to comprehensively score the risk factors of hospitalized patients with cerebral hemorrhage and evaluate the possibility of hematoma enlargement. Being able to identify high-risk patients with hematoma enlargement early and take intervention measures to save their lives.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on clinical data from 226 individuals diagnosed with spontaneous ICH between December 29, 2023, and August 29, 2024. Multiple logistic regression analysis was performed to identify risk factors associated with hematoma expansion. Predictive performance of the model was assessed using ROC curve analysis and receiver operating characteristic curve analysis. Mortality rates were calculated for each group following a 7-day follow-up period.</p><p><strong>Results: </strong>Hematoma expansion was associated with diabetes mellitus, a low Glasgow Coma Scale (GCS) score at admission, elevated systolic blood pressure at admission, coagulation abnormalities, and specific computed tomography (CT) imaging findings, such as heterogeneous density, black hole sign, swirl sign, lobulation sign, and blend sign. A prognostic model incorporating these factors demonstrated robust predictive performance, achieving an area under the curve of 0.771 (95% CI: 0.628-0.915, <i>p</i> = 0.002). The model yielded a maximum Youden index of 0.489, with an optimal cutoff score of 38, a sensitivity of 54.5%, and a specificity of 94.4%. Mortality among individuals with coagulation abnormalities was 53.3%.</p><p><strong>Conclusion: </strong>Coagulation abnormalities, GCS score, systolic blood pressure at admission, CT imaging findings, and diabetes mellitus were identified as predictors of hematoma expansion in spontaneous ICH. Individuals with coagulopathy and elevated systolic blood pressure at admission exhibited the poorest prognoses.</p>","PeriodicalId":56009,"journal":{"name":"Risk Management and Healthcare Policy","volume":"18 ","pages":"2865-2874"},"PeriodicalIF":2.0000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12415086/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Risk Management and Healthcare Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/RMHP.S534564","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Identifying risk factors associated with hematoma expansion following spontaneous intracerebral hemorrhage (ICH) is essential for improving early intervention strategies. We hope to use this predictive model in the future to comprehensively score the risk factors of hospitalized patients with cerebral hemorrhage and evaluate the possibility of hematoma enlargement. Being able to identify high-risk patients with hematoma enlargement early and take intervention measures to save their lives.
Methods: A retrospective analysis was conducted on clinical data from 226 individuals diagnosed with spontaneous ICH between December 29, 2023, and August 29, 2024. Multiple logistic regression analysis was performed to identify risk factors associated with hematoma expansion. Predictive performance of the model was assessed using ROC curve analysis and receiver operating characteristic curve analysis. Mortality rates were calculated for each group following a 7-day follow-up period.
Results: Hematoma expansion was associated with diabetes mellitus, a low Glasgow Coma Scale (GCS) score at admission, elevated systolic blood pressure at admission, coagulation abnormalities, and specific computed tomography (CT) imaging findings, such as heterogeneous density, black hole sign, swirl sign, lobulation sign, and blend sign. A prognostic model incorporating these factors demonstrated robust predictive performance, achieving an area under the curve of 0.771 (95% CI: 0.628-0.915, p = 0.002). The model yielded a maximum Youden index of 0.489, with an optimal cutoff score of 38, a sensitivity of 54.5%, and a specificity of 94.4%. Mortality among individuals with coagulation abnormalities was 53.3%.
Conclusion: Coagulation abnormalities, GCS score, systolic blood pressure at admission, CT imaging findings, and diabetes mellitus were identified as predictors of hematoma expansion in spontaneous ICH. Individuals with coagulopathy and elevated systolic blood pressure at admission exhibited the poorest prognoses.
期刊介绍:
Risk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of public health, policy and preventative measures to promote good health and improve morbidity and mortality in the population. Specific topics covered in the journal include:
Public and community health
Policy and law
Preventative and predictive healthcare
Risk and hazard management
Epidemiology, detection and screening
Lifestyle and diet modification
Vaccination and disease transmission/modification programs
Health and safety and occupational health
Healthcare services provision
Health literacy and education
Advertising and promotion of health issues
Health economic evaluations and resource management
Risk Management and Healthcare Policy focuses on human interventional and observational research. The journal welcomes submitted papers covering original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. Case reports will only be considered if they make a valuable and original contribution to the literature. The journal does not accept study protocols, animal-based or cell line-based studies.